Bliss GVS Pharma acquisition: Proven strategies for growth
Bliss GVS Pharma acquisition reshaped the market, boosting H1 revenue to INR 14,609.15 million. Discover the impact and strategies involved.
Bliss GVS Pharma acquisition reshaped the market, boosting H1 revenue to INR 14,609.15 million. Discover the impact and strategies involved.
Cancer drug prices may decrease as the government plans a 30% trade margin cap, offering potential savings for patients.
India pharma market growth shows a significant rise of 10.7% in August, driven by GLP-1 launches.